18:10:36 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-10-18 Kvartalsrapport 2024-Q3
2024-07-18 Kvartalsrapport 2024-Q2
2024-04-23 Ordinarie utdelning GETI B 4.40 SEK
2024-04-22 Årsstämma 2024
2024-04-22 Kvartalsrapport 2024-Q1
2024-02-01 Bokslutskommuniké 2023
2023-10-23 Kvartalsrapport 2023-Q3
2023-07-18 Kvartalsrapport 2023-Q2
2023-04-27 Ordinarie utdelning GETI B 4.25 SEK
2023-04-26 Kvartalsrapport 2023-Q1
2023-04-26 Årsstämma 2023
2023-02-01 Bokslutskommuniké 2022
2022-10-19 Kvartalsrapport 2022-Q3
2022-07-19 Kvartalsrapport 2022-Q2
2022-04-27 Ordinarie utdelning GETI B 4.00 SEK
2022-04-26 Kvartalsrapport 2022-Q1
2022-04-26 Årsstämma 2022
2022-01-28 Bokslutskommuniké 2021
2021-10-20 Kvartalsrapport 2021-Q3
2021-07-16 Kvartalsrapport 2021-Q2
2021-04-21 Ordinarie utdelning GETI B 3.00 SEK
2021-04-20 Kvartalsrapport 2021-Q1
2021-04-20 Årsstämma 2021
2021-01-28 Bokslutskommuniké 2020
2020-10-16 Kvartalsrapport 2020-Q3
2020-07-16 Kvartalsrapport 2020-Q2
2020-06-29 Ordinarie utdelning GETI B 1.50 SEK
2020-06-26 Årsstämma 2020
2020-04-22 Kvartalsrapport 2020-Q1
2020-01-30 Bokslutskommuniké 2019
2019-10-18 Kvartalsrapport 2019-Q3
2019-07-17 Kvartalsrapport 2019-Q2
2019-04-24 Ordinarie utdelning GETI B 1.00 SEK
2019-04-23 Kvartalsrapport 2019-Q1
2019-04-23 Årsstämma 2019
2019-01-30 Bokslutskommuniké 2018
2018-10-18 Kvartalsrapport 2018-Q3
2018-07-17 Kvartalsrapport 2018-Q2
2018-04-27 Ordinarie utdelning GETI B 1.50 SEK
2018-04-26 Årsstämma 2018
2018-04-26 Kvartalsrapport 2018-Q1
2018-01-29 Bokslutskommuniké 2017
2017-10-18 Kvartalsrapport 2017-Q3
2017-07-17 Kvartalsrapport 2017-Q2
2017-04-25 Kvartalsrapport 2017-Q1
2017-03-30 Ordinarie utdelning GETI B 2.00 SEK
2017-03-29 Årsstämma 2017
2017-01-26 Bokslutskommuniké 2016
2016-10-18 Kvartalsrapport 2016-Q3
2016-07-14 Kvartalsrapport 2016-Q2
2016-04-22 Kvartalsrapport 2016-Q1
2016-03-31 Ordinarie utdelning GETI B 2.80 SEK
2016-03-30 Årsstämma 2016
2016-01-28 Bokslutskommuniké 2015
2015-10-15 Kvartalsrapport 2015-Q3
2015-09-02 Extra Bolagsstämma 2015
2015-07-15 Kvartalsrapport 2015-Q2
2015-04-20 Kvartalsrapport 2015-Q1
2015-03-26 Ordinarie utdelning GETI B 2.80 SEK
2015-03-25 Årsstämma 2015
2015-01-28 Bokslutskommuniké 2014
2014-10-16 Kvartalsrapport 2014-Q3
2014-10-16 Analytiker möte 2014
2014-07-15 Kvartalsrapport 2014-Q2
2014-04-16 Kvartalsrapport 2014-Q1
2014-03-21 Ordinarie utdelning GETI B 4.15 SEK
2014-03-20 Årsstämma 2014
2014-01-28 Bokslutskommuniké 2013
2013-10-15 Analytiker möte 2013
2013-10-15 15-7 2013
2013-10-15 Kvartalsrapport 2013-Q3
2013-07-11 Kvartalsrapport 2013-Q2
2013-04-17 Kvartalsrapport 2013-Q1
2013-03-22 Ordinarie utdelning GETI B 4.15 SEK
2013-03-21 Årsstämma 2013
2013-02-08 Kapitalmarknadsdag 2013
2013-01-25 Bokslutskommuniké 2012
2012-10-17 Kvartalsrapport 2012-Q3
2012-10-17 Analytiker möte 2012
2012-07-11 Kvartalsrapport 2012-Q2
2012-04-19 Kvartalsrapport 2012-Q1
2012-03-29 Ordinarie utdelning GETI B 3.75 SEK
2012-03-28 Årsstämma 2012
2012-01-26 Bokslutskommuniké 2011
2011-10-20 Kvartalsrapport 2011-Q3
2011-07-11 Kvartalsrapport 2011-Q2
2011-04-28 Ordinarie utdelning GETI B 3.25 SEK
2011-04-27 Årsstämma 2011
2011-04-27 Kvartalsrapport 2011-Q1
2011-01-28 Kapitalmarknadsdag 2011
2011-01-26 Bokslutskommuniké 2010
2010-10-19 Kvartalsrapport 2010-Q3
2010-04-23 Ordinarie utdelning GETI B 2.75 SEK
2010-04-22 Ordinarie utdelning GETI B 2.75 SEK
2010-04-21 Årsstämma 2010
2010-04-21 Kvartalsrapport 2010-Q1
2010-01-26 Bokslutskommuniké 2009
2009-07-13 Kvartalsrapport 2009-Q2
2009-05-06 Kvartalsrapport 2009-Q3
2009-04-22 Ordinarie utdelning GETI B 2.40 SEK
2009-04-21 Årsstämma 1
2009-04-21 Kvartalsrapport 2009-Q1
2008-04-18 Ordinarie utdelning GETI B 2.40 SEK
2007-04-20 Ordinarie utdelning GETI B 2.20 SEK
2006-04-21 Ordinarie utdelning GETI B 2.00 SEK
2005-04-20 Ordinarie utdelning GETI B 1.65 SEK
2004-04-22 Ordinarie utdelning GETI B 1.35 SEK
2003-11-25 Split GETI B 1:4
2003-04-24 Ordinarie utdelning GETI B 4.25 SEK
2002-04-19 Ordinarie utdelning GETI B 3.75 SEK
2001-04-24 Ordinarie utdelning GETI B 3.50 SEK
2000-04-28 Ordinarie utdelning GETI B 3.50 SEK
1999-04-22 Ordinarie utdelning GETI B 3.25 SEK
1998-04-24 Ordinarie utdelning GETI B 2.75 SEK
1997-04-30 Ordinarie utdelning GETI B 2.50 SEK
1996-04-19 Ordinarie utdelning GETI B 6.00 SEK

Beskrivning

LandSverige
ListaLarge Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
Getinge är en global leverantör av tekniska lösningar för sjukvårdsindustrin. Bolaget är en utvecklare samt tillverkare av lösningar som används inom operationssalar, intensivvårdsenheter och sterilcentraler. Bolagets produkter används exempelvis för infektionskontroll, bland IT-system, patienthantering, samt vid vård av kraftigt överviktiga patienter. Huvudkontoret ligger i Göteborg.
2023-04-26 08:00:00

"The order intake and net sales increased organically by 2.9% and 7.5%, respectively, during the quarter", says Mattias Perjos, President & CEO. "The higher sales volumes, price increases and positive currency effects contributed to both gross and operating profit strengthening, despite higher costs for purchases of both input goods and services as well as salaries."

Getinge's increased sales was mainly a result of high demand for ventilators for the expansion of intensive care in China, a recovery in cardiovascular procedures and major deliveries in Surgical Workflows to meet demand for productivity-enhancing infrastructure in healthcare. The company's supply chain constraints eased in the quarter and are now mainly concentrated to intra-aortic balloon pumps and ECMO therapy products in Acute Care Therapies, for which orders valued at just over SEK 400 M are pending delivery during the second half of the year.

"It is gratifying that we, in the quarter, received premarket approval (PMA) in the US from the FDA for the iCast™ stent system for the treatment of patients with iliac arterial occlusive disease", says Mattias Perjos, President & CEO. "We expect that this will start to contribute to higher sales and stronger margins for Acute Care Therapies from the fourth quarter this year."

In March, Getinge reported the suspension of the CE certificate and quality-related field safety corrective actions for its intra-aortic balloon pump. The CE certificate was also suspended for ECMO therapy consumables due to packaging deficiencies. However, deliveries to existing customers have been approved in accordance with EU regulations, due to the benefits provided by the products.

Free cash flow was better than in the year-earlier period excluding large payments related to the final settlement regarding surgical mesh products. Getinge's financial position remains solid with low net debt.

January - March 2023 in brief
  • Net sales increased organically by 7.5% and the order intake increased organically by 2.9%
  • Adjusted gross profit amounted to SEK 3,734 M (3,261) and the gross margin was 52.3% (52.7)
  • Adjusted EBITA amounted to SEK 972 M (839) and the EBITA margin was 13.6% (13.6)
  • Adjusted earnings per share amounted to SEK 2.34 (2.11)
  • Free cash flow amounted to SEK -700 M (420)

 

Phone Conference

A conference call will be held on April 26, 2023, at 10:00-11:00 a.m. CEST hosted by Mattias Perjos, President & CEO, and Lars Sandström, CFO.

To participate via teleconference, please register via this link (https://conference.financialhearings.com/teleconference/?id=200641). After registration, you will be provided with telephone numbers and a conference ID to access the conference. You can ask questions verbally via the telephone conference.

During the conference call a presentation will be held. To access the presentation through webcast, please use this link (https://ir.financialhearings.com/getinge-q1-2023). A recorded version can be accessed here (https://ir.financialhearings.com/getinge-q1-2023) for 3 years.

Media contact:

Lars Mattson, Head of Investor Relations
Phone: +46 (0)10 335 0043
Email: lars.mattsson@getinge.com 
 

This information is such that Getinge AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Swedish Securities Market Act. The information was submitted for publication, through the agency of the contact person set out above, on April 26, 2023, at 08:00 a.m. CEST.

About Getinge

With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions that aim to improve clinical results and optimize workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Getinge employs over 10,000 people worldwide and the products are sold in more than 135 countries.